[Excellent response to lanreotide treatment of thyrotropin and prolactin secreting pituitary macroadenoma].
Murillo Sanchís
J
J
Martín
A L
AL
Salinas Vert
I
I
Sanmartí Sala
A
A
D000236:Adenoma / Q000188:drug therapy* / Q000378:metabolism; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011388:Prolactin / Q000378:metabolism; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013972:Thyrotropin / Q000378:metabolism
D000970:Antineoplastic Agents; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D011388:Prolactin; D013972:Thyrotropin